BMC Biotechnol. 2026 Apr 13;26(1):46. doi: 10.1186/s12896-026-01139-9.
NO ABSTRACT
PMID:41975372 | DOI:10.1186/s12896-026-01139-9
Tag: statistics
BMC Public Health. 2026 Apr 13;26(1):1196. doi: 10.1186/s12889-026-27021-z.
NO ABSTRACT
PMID:41975363 | DOI:10.1186/s12889-026-27021-z
BMC Public Health. 2026 Apr 13. doi: 10.1186/s12889-026-27340-1. Online ahead of print.
NO ABSTRACT
PMID:41975355 | DOI:10.1186/s12889-026-27340-1
BMC Geriatr. 2026 Apr 13. doi: 10.1186/s12877-026-07420-y. Online ahead of print.
ABSTRACT
BACKGROUND: Chronic non-specific low back pain (CNLBP) is an important health problem affecting people of all ages in societies. This health problem increases especially with age and participation restrictions and quality of life are negatively affected accordingly. This study was conducted to investigate the participation levels, pain, kinesiophobia, functional status and depression among older adults with CNLBP.
METHOD: This descriptive and correlational study included 115 cognitively healthy older people over the age of 65 who applied to a state hospital with CNLBP. Data were collected using the Demographic Information Form, Montreal Cognitive Assessment, Visual Analog Scale, Tampa Scale of Kinesiophobia, Back Pain Function Scale, Keele Participation Assessment Scale and Geriatric Depression Scale. Data were evaluated using descriptive statistics, independent sample t-test, correlation and regression analyses.
RESULTS: The mean age of the older adults participating in the study was 71.90 ± 6.64. According to the results obtained, it was found that as the level of social participation of the older adults decreased, their depression, kinesiophobia and pain levels increased and their functional levels decreased. It was determined that social participation could explain 45% of functional losses and 20-25% of psychological symptoms.
CONCLUSION: According to the findings, CNLBP has critical effects not only on the physical but also on the psychosocial status of the older people. Therefore, incorporating psychosocial factors affecting older adults into holistic rehabilitation plans is key to the successful treatment of CNLBP.
TRIAL REGISTRATION: Not applicable.
PMID:41975332 | DOI:10.1186/s12877-026-07420-y
BMC Geriatr. 2026 Apr 13. doi: 10.1186/s12877-026-07469-9. Online ahead of print.
NO ABSTRACT
PMID:41975329 | DOI:10.1186/s12877-026-07469-9
BMC Infect Dis. 2026 Apr 14. doi: 10.1186/s12879-026-13275-w. Online ahead of print.
NO ABSTRACT
PMID:41975325 | DOI:10.1186/s12879-026-13275-w
BMC Infect Dis. 2026 Apr 13. doi: 10.1186/s12879-026-13314-6. Online ahead of print.
ABSTRACT
INTRODUCTION: Critically ill children with adenoviral pneumonia usually require intensive care treatment. In this study, the prevalence of viremia secondary to respiratory adenovirus infection and the host characteristics and inflammatory response of children with severe adenoviral pneumonia in the PICU were investigated.
METHODS: We prospectively recruited children who were admitted to the PICU of a tertiary pediatric hospital due to severe adenoviral pneumonia from September 2022 to April 2025. Sputum and blood samples were tested for adenovirus DNA with polymerase chain reaction. The clinical characteristics, blood laboratory parameters, and outcomes of the patients were collected. Plasma cytokines were also detected by flow cytometry.
RESULTS: Fifty-one patients with severe adenoviral pneumonia were enrolled, 20 of whom had viremia. The proportion of children with comorbidities in the viremia group and nonviremia group was 40.0% and 71.0%, respectively. The viral loads in sputum; CRP, PCT, D-dimer, AST, LDH, IL-6, IL-8, IL-10, and IFN-γ levels; and pSOFA, PSS and PRISM-Ⅲ scores were significantly greater in the viremia group than in the nonviremia group, whereas the IL-5 and albumin levels were markedly lower in the viremia group. The number of Natural killer cells in the viremia group was lower than that in the nonviremia group, but there was no statistical difference. Multivariate logistic regression found that sputum viral load was an independent risk factor associated with viremia. The areas under the receiver operating characteristic curves for AST, LDH, PCT, CRP, D-dimer, IL-6 and IFN-γ could predict viremia. The mortality rate of the viremia group was higher than that of the nonviremia group, while the difference was not significant.
CONCLUSIONS: The prevalence of viremia is nearly 40% in children with severe adenoviral pneumonia in the PICU. Compared with the nonviremia group, the viremia group had higher sputum viral loads, CRP, PCT, IL-6, IL-8, IL-10, and IFN-γ levels; and more serious disease severity.
PMID:41975305 | DOI:10.1186/s12879-026-13314-6
BMC Geriatr. 2026 Apr 14. doi: 10.1186/s12877-026-07428-4. Online ahead of print.
NO ABSTRACT
PMID:41975302 | DOI:10.1186/s12877-026-07428-4
BMC Geriatr. 2026 Apr 14. doi: 10.1186/s12877-026-07458-y. Online ahead of print.
NO ABSTRACT
PMID:41975301 | DOI:10.1186/s12877-026-07458-y
Gut Microbes. 2026 Dec 31;18(1):2655793. doi: 10.1080/19490976.2026.2655793. Epub 2026 Apr 13.
ABSTRACT
Primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) are rare, idiopathic, chronic cholestatic liver diseases that respond differently to limited medical therapies and often lead to liver transplantation. We examined the compositional and functional differences in the gut microbiome, mycobiome, and metabolome of these diseases to better understand their impact on pathogenesis and outcomes. Stool sample metagenomes and metabolomes from patients with PSC (n = 245), PBC (n = 280) and matched controls (n = 245 and n = 278, respectively) were analyzed by shotgun sequencing and ultrahigh-resolution mass spectrometry. Comparisons were conducted with covariate-adjusted linear models. The gut microbiomes of patients with PSC and PBC were characterized by reduced diversity and increased abundance of pathobionts and virulence factors, coupled with altered microbial metabolism, including a reduction of short-chain fatty acids and B-vitamins. Untargeted stool metabolomics supported these results. Patients were stratified into groups using their microbial signatures, and each group had distinct patterns of microbiome-related changes. Cox regression analysis revealed that pathogenic microbial species were predictive of hepatic decompensation, whereas beneficial species had a protective effect. Based on previous groundwork and our new results, microbiome-based interventions such as probiotics, short-chain fatty acid supplementation, and phage therapy represent promising therapeutic options for cholestatic liver diseases.
PMID:41975274 | DOI:10.1080/19490976.2026.2655793